Curriculum Vitae

Download this CV as a PDF

Last Updated 4/08

1. Report of Research

   1. Major Research Interests:

      • Diagnosis and treatment of psychotic and affective disorders
      • Etiology and treatment of eating disorders
      • Psychopharmacology
      • Drug Abuse
      • The “repressed” and “recovered” memory controversy

   2. Narrative Description of Research

      I have performed studies in many different areas of biological psychiatry over the course of the years. Starting in the late 1970s, my work on the diagnosis and classification of psychotic and affective disorders helped to stimulate revised diagnostic criteria for these disorders in DSM-III and subsequent diagnostic manuals. In the early 1980s, I conducted studies demonstrating the relationship of the eating disorders to major mood disorders, and was the first to publish a placebo-controlled, double blind study showing antidepressants to be effective in the treatment of bulimia nervosa. Throughout this same period, I conducted numerous studies in various aspects of psychopharmacology. Notable among these were the first published case series describing the “serotonin syndrome,” a major series of studies investigating the neuroleptic malignant syndrome, several additional open-label and placebo-controlled, double-blind studies of antidepressants in bulimia nervosa, and studies of anticonvulsants in the treatment of major mood disorders. Among the latter was the first large placebo-controlled study to demonstrate that valproate was effective for the manic phase of bipolar disorder.

      Starting in the 1990s, I focused increasingly on studies on substance abuse, including cannabis, hallucinogens, “ecstasy,” and anabolic steroids. I have published extensively on the neuropsychological effects of long-term cannabis use and related topics; neuropsychological performance among long-term hallucinogen users; and a pilot study of the neuropsychological effects of “ecstasy” use. Currently I am in the midst of a five-year study looking at the long-term or psychological effects of ecstasy in a much larger sample of users. In the area of anabolic steroids, I have published numerous papers over the last 20 years covering various aspects of anabolic steroid abuse, with particular attention to the psychiatric effects of steroids; among other studies, I have conducted the largest placebo-controlled study looking at the psychiatric effects of supraphysiologic doses of steroids, and I have performed several field studies looking at attributes of illicit steroid users and risk factors for steroid use.

      Also starting in the 1990s, I became interested in the important theoretical issue of “repressed memory,” (dissociative amnesia) and have published a series of papers and a book assessing the validity of the concept of “repressed memory,” and examining the related topics of childhood sexual abuse and other traumas.

      Finally, in collaboration with Dr. James Hudson, I have pursued a series of studies on the concept of “affective spectrum disorder” – the hypothesis that there is a large group of psychiatric and medical disorders that may share a common and possibly heritable physiologic abnormality. Following an initial presentation of this hypothesis (reference number 100 below), we have published a series of additional papers, including reports of recent large family studies, exploring this issue.

      My research activities also include teaching work with medical students, psychiatric residents, and junior investigators over the years, assisting them in conducting studies in numerous areas of psychiatry.

   3. Research Funding Information:

      Past:

      1979-1981	NIDA - Co-Investigator Assessing the subjective effects of drugs in casual users
      1981-1989	NIMH - Co-investigator Collaborative biological studies of schizophrenia
      1982-1983	NIMH/Small grant - Principal Investigator Familial hyperkalemic periodic paralysis and manic-depressive illness: a linkage study
      1986	Hoechst-Roussel Pharmaceuticals - Co-Investigator Nomifensine in the treatment of bulimia nervosa
      1985-1986	Burroughs Wellcome Co. - Co-Investigator Bupropion vs. placebo in the treatment of bulimia nervosa
      1986-1987	NIMH/R01 - Co-Investigator (Site Director) Test-Retest Reliability of the Structured Clinical Interview for DSM-III-R
      1986-1987	Eli Lilly & Co. - Co-Investigator Fluoxetine vs. placebo in the treatment of bulimia nervosa
      1986-1987	Mead Johnson Pharmaceuticals - Principal Investigator Trazodone vs. placebo in the treatment of bulimia nervosa
      1987-1989	Abbott Laboratories - Principal Investigator Valproate vs. placebo in the treatment of acute mania
      1988-1989	Eli Lilly & Co. - Co-Investigator Fluoxetine vs. placebo in the long-term treatment of bulimia nervosa
      1990-1991	Eli Lilly & Co. - Co-Investigator Fluoxetine vs. placebo in the treatment of kleptomania
      1991-1992	Glaxo Pharmaceuticals - Co-Investigator Ondansetron vs. diazepam vs. placebo in the treatment of generalized anxiety disorder
      1991-1992	Eli Lilly & Co. - Co-Investigator Zatosetron vs. lorazepam vs. placebo in the treatment of generalized anxiety disorder
      1991-1992	Abbott Laboratories - Co-Investigator Long-term follow-up of manic patients treated with valproate
      1990-1993	NIDA/RO1-06543 - Principal Investigator Psychiatric effects of anabolic steroids
      1990-1994	Harvard Medical School/Milton Fund - Co-Investigator Genetic epidemiology of affective spectrum disorder
      1991-1994	NIDA/RO1-06522 - Principal Investigator Neuropsychological effects of marijuana in college students
      1992-1993	Ciba-Geigy Co. - Co-Investigator Brofaromine vs. placebo in the treatment of social phobia
      1992-1994	Pfizer, Inc. - Co-Investigator CP-93,393 vs. placebo in the treatment of generalized anxiety disorder
      1992-1994	Pfizer, Inc. - Co-Investigator CP-93,393 vs. placebo in the treatment of major depression
      1993-1994	The Upjohn Co. - Co-Investigator Fluvoxamine vs. placebo in the treatment of binge eating disorder
      1993-1994	Ciba-Geigy Co. - Co-Investigator Placebo-controlled, dose ranging trial of oxcarbazepine in hospitalized inpatients with acute mania.
      1993-1995	Abbott Laboratories - Principal Investigator Safety and efficacy of Depakote in the prevention of mania in patients with bipolar disorder.
      1994-1996	Glaxo, Inc. - Co-Investigator Ondansetron vs. placebo in the treatment of panic disorder
      1994-1996	The Upjohn Co. - Co-Investigator Pramipexole vs. placebo in the treatment of severe depression
      1995-1996	GlaxoWellcome. - Co-Investigator Family study of panic disorder
      1994-1996	Pfizer, Inc. - Co-Investigator CP 93,393-1 in patients with major depressive disorder
      1993-1997	NIDA/R01-DA06543 - Principal Investigator Psychiatric Effects of Testosterone in Normal Men
      1996-1997	Pfizer, Inc. Co-Investigator CP 93,393-1 vs. placebo in the treatment of generalized anxiety disorder
      1996-1997	Pfizer, Inc. - Co-Investigator CP 93,393-1 vs. fluoxetine vs. placebo in the treatment of major depressive disorder
      1996-1997	Eli Lilly & Company - Co-Investigator Fluoxetine vs. placebo in bulimia relapse prevention
      1996-1998	NIDA/R01- DA10055 - Principal Investigator A Controlled Study of Anabolic Steroid Use in Women
      1997-1998	Glaxo Wellcome, Inc. - Principal Investigator Evaluation of Lamotrigine in the long-term prevention of mood episodes in patients with rapid cycling bipolar disorder
      1996-2000	NIDA/R01- DA10346 - Principal Investigator Cognitive Consequences of Long-Term Marijuana Use
      1998-2000	CEASE, Inc. - Principal Investigator Development of a website to educate people about abuse of anabolic androgenic steroids
      1999-2001	Webster Foundation - Principal Investigator Affective Spectrum Disorder
      1999-2002	CEASE, Inc. - Principal Investigator Substance Use in Male Weightlifters
      2001-2002	Unimed Pharmaceutical Co., Inc. - Principal Investigator Testosterone gel in men with major depressive disorder with low or borderline testosterone levels
      2000-2004	NIDA/R37-DA10346 (MERIT AWARD)- Principal Investigator Cognitive consequences of long-term marijuana use
      2003-2005	Ortho-McNeil Pharmaceutical - Co-Investigator Topiramate vs. placebo in the treatment of binge eating disorder
      Current
      2002-	Ortho-McNeil Pharmaceutical - Co-Principal Investigator Family and genetic study of binge eating disorder
      2005-	NIDA/R01 DA16744-01 A2 - Principal Investigator Risk factors for anabolic-androgenic steroid abuse
      2005-	NIDA/R01 DA 017953 - Co-Investigator Neurocognitive consequences of long-term ecstasy use
      2005-	Eli Lilly & Company - Principal Investigator A Comparison of LY686017, Paroxetine, and Placebo in the Treatment of Social Anxiety Disorder
      2006-	Solvay Pharmaceuticals - Principal Investigator A Parallel-Group, Placebo-Controlled Trial of Androgel in Men with Major Depressive Disorder Who Display an Incomplete Response to Standard Antidepressant Treatment

   4. Principal Clinical and Hospital Service Responsibilities:

      1977-1979	Psychiatrist-in-Charge, Clinical Evaluation Unit for Study of Psychotic Disorders, Laboratories for Psychiatric Research, McLean Hospital
      1990-	Research Committee, McLean Hospital

2. Report of Teaching:

   Local Contributions

   McLean Hospital
   1980-	Psychopathology Lecturer on psychiatric disorders and eating disorders 10-12 residents in psychiatry 1-3 hours/year
   1982-	Psychopharmacology Lecturer on pharmacologic treatment of psychotic disorders and eating disorders 10-12 residents in psychiatry 1-3 hours/year
   1983-	Psychopharmacology Lecturer 8-10 medical students 1 hour/year
   1991	Psychopharmacology Luncheon Speaker on psychotic disorders, eating disorders, and substance abuse 20-30 staff psychiatrists, residents in psychiatry, and other hospital staff members 2 hours/year
   1993-	Psychopharmacology Supervise PGY-III residents on consultation service 6-10 residents/year 24 hours/year
   1993-	Alcohol and drug abuse Lecturer on substance abuse 20-50 staff psychiatrists, residents in psychiatry, and other hospital staff members 2 hours/year
   Massachusetts Mental Health Center
   1986	Psychopathology Lecturer on diagnosis of psychotic disorders 10-12 residents in psychiatry 2 hours
   Massachusetts General Hospital
   1994	Psychopathology/case presentation and discussion Residents in psychiatry and nursing staff 2 hours
   Harvard Medical School
   1995-	Alcohol and drug abuse Lecturer on substance abuse 10-15 medical students 2 hours per year
   Harvard College
   2004-	Anabolic steroid and ecstasy abuse Lecturer on substance abuse for Dr. Franz Schneider 12-15 students 2 hours per year

   Advising Responsibilities

   1982-	Supervisor for residents in psychiatry on clinical and research activities 1-2 residents/year
   1990-	Preceptor for residents in psychiatry 1-2 residents per year

   Regional, National, and International Contributions

   Invited Presentations
   1982-	Lectures at approximately 20 regional and national courses on psychotic disorders, eating disorders, psychopharmacology, and substance abuse sponsored by academic institutions, hospitals, professional societies, and self-help organizations
   1984	Invited Speaker, International Conference on Eating Disorders
   1986	Plenary Speaker, International Conference on Eating Disorders
   1986	Invited Speaker, Second International Conference on Eating Disorders, Sydney, Australia
   1986	Chairperson, Symposium on Neuroleptic Malignant Syndrome American Psychiatric Association, Washington, DC
   1990	Chairperson, Symposium on Anticonvulsants in Treatment of Psychiatric Disorders, American Psychiatric Association, Montreal, Canada
   1996	Gast professur (Guest Professor) Department of Psychiatry, University Clinics of Innsbruck, Innsbruck, Austria Lectured on affective spectrum disorder, eating disorders, psychopharmacology, and childhood sexual abuse

   Teaching of Research Methods to Junior Investigators:

   1981-

   Principal teaching activity since 1977 has been the teaching of junior investigators in how to design, conduct, and publish research studies Since 1982, the following trainees have participated under supervision in projects resulting in their authorship on one or more published research studies in peer-reviewed scientific journals: 1 Pre-college summer intern 2 college undergraduates (thesis advisor for two honors theses, one at Harvard and one at Tufts) 2 Masters candidates (One at Yale, One at Harvard) 4 Ph.D candidates (Harvard University, USA; University of London, U.K.; and University of Innsbruck, Austria) 4 Research Assistants/Pre-Med Students 1 Medical Student 3 Post-doctoral Fellows (1 United States, 2 Canada) 21 Psychiatric Residents (20 at McLean Hospital, 1 in Sao Paulo, Brazil) During their training periods, these junior trainees have collectively become authors with Dr. Pope on 73 original articles in peer-reviewed journals and 20 reviews and book chapters

3. Clinical Activities

   1. Short report of clinical activities
   1977-	General private clinical practice of psychiatry, with emphasis on biological treatment of patients with psychotic disorders, major mood disorders, and eating disorders. Current practice is restricted to consultation time averaging less than four hours per week.

Bibliography:

Original Reports:

1. Pope HG Jr. Tabernanthe iboga: an African narcotic plant of social importance. Economic Botany 1969;23:174-84.
2. Walters PA, Jr., Goethals GW, Pope HG Jr. Drug use and life-style among 500 college undergraduates. Arch Gen Psychiatry 1972;26:92-6.
3. Hirsch MS, Moellering RC, Jr, Pope HG, Jr, Poskanzer DC. Lymphocytic- choriomeningitis-virus infection traced to a pet hamster. New Eng J Med 1974;291:610- 12.
4. Cole JO, Swett CP, Pope HG Jr. Agranulocytosis revisited. McLean Hosp J 1975;1:349.
5. Pope HG Jr. From schizophrenia to affective illness: a question of diagnosis. McLean Hosp J 1976;2:108-19.
6. Pope HG Jr, Lipinski J. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of “schizophrenic” symptoms in the light of current research. Arch Gen Psychiatry 1978;35:811-28.
7. Cole JO, Pope HG Jr, LaBrie R, Ionescu-Pioggia M. Assessing the subjective effects of stimulants in casual users: methodology and preliminary results. Clin Pharmacol Therap 1978;24:243-52.
8. Pope HG Jr. Drug Abuse and psychopathology. New Eng J Med 1979; 301:1341-43.
9. Cohen BM, Lipinski JF, Pope HG Jr, Harris PQ. Neuroleptic blood levels of patients on thioridazine and clinical improvement. Psychopharmacology 1980;70:191-3.
10. Cohen BM, Lipinski JF, Harris PQ, Sherman M, Pope HG Jr. Clinical use of the radioreceptor assay for neuroleptics. Psychiatry Res 1980;2:173-8.
11. Pope HG Jr, Lipinski JF, Cohen BM, Axelrod D. Schizoaffective disorder: an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. Am J Psychiatry 1980;137:921-7.
12. Cohen BM, Miller AL, Lipinski JF, Pope HG Jr. Lecithin in mania: a preliminary report. Am J Psychiatry 1980;137:242-3.
13. Cohen BM, Harris PQ, Pope HG Jr, Altesman RI, Lipinski JF. Radioreceptor assays in clinical psychiatric research. Psychopharmacology Bull 1980;16:82-4.
14. Pope HG Jr, Ionescu-Pioggia M, Cole JO. Drug use and life-style among college undergraduates–nine years later. Arch Gen Psychiatry 1981;38:588-91.
15. Hudson JI, Laffer PS, Pope HG Jr. Bulimia related to affective disorder by family history and response to the dexamethasone suppression test. Am J Psychiatry 1982;139:685-7.
16. Pope HG Jr, Jonas JM, Cohen BM, Lipinski JF. Failure to find evidence of schizophrenia in the first-degree relatives of schizophrenics. Am J Psychiatry 1982;139:826-8.
17. Lipinski JF, Pope HG Jr. Possible synergistic action between carbamazepine and lithium carbonate: a report of three cases. Am J Psychiatry 1982;139:948-9.
18. Fogelson DL, Cohen BM, Pope HG Jr. A study of the validity of DSM-III schizophreniform disorder. Am J Psychiatry 1982;139:1281-5.
19. Pope HG Jr, Jonas JM, Jones B. Factitious psychosis: phenomenology, family history, and long-term outcome of nine cases. Am J Psychiatry 1982;139:1480-3.
20. Pope HG Jr, Hudson JI. Treatment of bulimia with antidepressants. Psychopharmacology 1982;78:176-9.
21. Pope HG Jr, Jonas JM, Hudson JI, Cohen BM, Gunderson JG. Borderline personality disorder: a phenomenologic, family history, treatment response, and long-term follow-up study. Arch Gen Psychiatry 1983;40:23-30.
22. Hudson JI, Pope HG Jr, Jonas JM, Yurgelun-Todd D. Family history study of anorexia nervosa and bulimia. Brit J Psychiatry 1983; 142:133-8.
23. Hudson JI, Pope HG Jr, Jonas JM, Laffer PS, Hudson MS, Melby JC. Hypothalamic- pituitary-adrenal axis hyperactivity in bulimia. Psychiatry Res 1983;8:111-7.
24. Pope HG Jr. Distinguishing bipolar disorder from schizophrenia in clinical practice: guidelines and case reports. Hosp Community Psychiatry 1983;34:322-8.
25. Pope HG Jr, Ionescu-Pioggia M, Yurgelun-Todd D. Migration and manic depressive illness. Compr Psychiatry 1983;24;158-65.
26. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled double-blind study. Am J Psychiatry 1983;140:554-8.
27. Pope HG Jr, Hudson JI, Jonas JM. Antidepressant treatment of bulimia: preliminary experience and practical recommendations. J Clin Psychopharmacol 1983;3:274-81.
28. Hudson JI, Pope HG Jr., Jonas JM, Yurgelun-Todd D. Phenomenologic relationship of eating disorders to major affective disorder. Psychiatry Res. 1983;9:345-54.
29. Zubenko G, Pope HG Jr: Management of a case of neuroleptic malignant syndrome with bromocriptine. Am J Psychiatry 1983;140:1619-20.
30. Jonas JM, Hudson JI, Pope HG, Jr. Treatment of bulimia with MAO inhibitors. J Clin Psychopharmacol 1983;3:59-60.
31. Pope HG Jr, Hudson JI, Yurgelun-Todd D. Anorexia nervosa and bulimia among 300 suburban women shoppers. Am J Psychiatry 1984;141:292-4.
32. Pope HG Jr, Hudson JI, Yurgelun-Todd D, Hudson MS. Prevalence of anorexia nervosa and bulimia in three student populations. Int J Eat Disord 1984;3:45-51.
33. Hudson JI, Pope HG Jr, Jonas JM. Psychosis in anorexia nervosa and bulimia. Br J Psychiatry 1984;145:420-3.
34. Jonas JM, Pope HG Jr, Hudson JI, Satlin A. Unexplained vomiting in a 56-year-old woman: An unsuspected case of bulimia. Am J Psychiatry 1984;141:902-3.
35. Pope HG Jr, Hudson JI, Poskanzer D, Yurgelun-Todd D. Familial hyperkalemic periodic paralysis and bipolar disorder: a linkage and treatment study. Biol Psychiatry 1984;19:1449-59.
36. Jonas JM, Pope HG Jr. Psychosis in borderline personality disorder. Psychiatric Developments 1984;4:295-308.
37. Hudson JI, Pope HG Jr, Jonas JM, Yurgelun-Todd D. Treatment of anorexia nervosa with antidepressants. J Clin Psychopharmacol 1985;5:17-23.
38. Jonas JM, Pope HG Jr. The dissimulating disorders: a single diagnostic entity? Comp Psychiatry 1985;26:58-62.
39. Hudson JI, Wentworth SM, Hudson MS, Pope HG Jr: Prevalence of anorexia nervosa and bulimia among young women with diabetes. J Clin Psychiatry 1985;46:88-93.
40. Hudson JI, Hudson MS, Plinier LF, Goldenberg DL, Pope HG Jr. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1985;142:441-6.
41. Pope HG Jr, Jonas JM, Hudson JI, Kafka MP. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan. Am J Psychiatry 1985;142:491-2.
42. Weiss RW, Pope HG Jr, Mirin SM. Treatment of cocaine abuse and attention deficit disorder, residual type with magnesium pemoline. Drug Alcohol Dep 1985;15:69-72.
43. Pope HG Jr, Jonas JM, Hudson JI, Cohen BM, Tohen M. Psychosis in borderline personality disorder: an empirical study. Am J Psychiatry 1985;142:1285-90.
44. Pope HG Jr, Hudson JI, Mialet J-P: Bulimia in nineteenth century France: the observations of Pierre Janet. Psychological Med 1985;15:739-43.
45. Herridge PL, Pope HG Jr. Treatment of bulimia and rapid-cycling bipolar disorder with sodium valproate. J Clin Psychopharmacol 1985;5:229-30.
46. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D: Antidepressant treatment of bulimia: a two-year follow-up study. J Clin Psychopharmacol 1985;5:320-7.
47. Hudson JI, Pope HG Jr, Jonas JM. Antidepressant treatment of bulimia. Adv Behav Res Ther 1985;7:173-9.
48. Pope HG Jr, Hudson JI, Nixon RA, Herridge PL. The epidemiology of ipecac abuse. New Engl J Med 1986;14:245-6.
49. Pope HG Jr, Hudson JI, Jonas JM. Bulimia in men: a series of 15 cases. J Nerv Ment Dis 1986;74:117-9.
50. Pope HG Jr, Herridge PL, Hudson JI, Fontaine R, and Yurgelun-Todd D. Treatment of bulimia with nomifensine. Am J Psychiatry 1986;143:371-3.
51. Linden R, Jonas JM, Pope HG, Jr: Pathological gambling and major affective disorder: preliminary findings. J Clin Psychiatry 1986;47:201-3.
52. Pope HG Jr, Hudson JI. Antidepressant drug therapy of bulimia: current status. J Clin Psychiatry 1986;47:339-45.
53. Pope HG Jr, Cole JO, Choras T, Fulwiler CE. Apparent neuroleptic malignant syndrome with clozapine and lithium. J Nerv Ment Dis 1986; 174:493-5.
54. Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1986;143:1227-33.
55. Pope HG Jr, Hudson JI, Zubenko GS, Jonas JM, Herridge PL. Schizoid personality disorder among psychiatric inpatients. McLean Hosp J 1986;9:1-9.
56. Hudson JI, Pope HG Jr. Newer antidepressants in the treatment of bulimia. Psychopharmacol Bull 1987;23:52-7.
57. McElroy SL, Keck PE Jr, Pope HG Jr. Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol 1987;7:16-24.
58. Pope HG Jr, Katz DL: Bodybuilder’s psychosis. Lancet 1987;1:863.
59. Hudson JI, Katz DL, Pope HG Jr, Hudson MS, Griffing GT, Melby JC. Urinary free cortisol and response to the dexamethasone suppression test in bulimia: a pilot study. Int J Eat Disord 1987;6:191-8.
60. Pope HG Jr, Frankenburg FR, Hudson JI, Jonas JM, Yurgelun-Todd D. Is bulimia associated with borderline personality disorder? J Clin Psychiatry 1987;48:181-4.
61. Hudson JI, Pope HG Jr, Jonas, JM, Stakes JW, Grochocinski VJ, Lipinski JF, Kupfer DJ. Sleep EEG in bulimia. Biol Psychiatry 1987;22:820-8.
62. Keck PE Jr, Pope HG Jr, McElroy SL. Frequency of the neuroleptic malignant syndrome: experience in France and in the United States. Psychiatr Psychobiol 1987;2:59-63.
63. Pope HG Jr, Hudson JI: Antidepressant medication in the treatment of bulimia nervosa. Psychopathology l987;Suppl. 1:123-9.
64. Pope HG Jr, Champoux R, Hudson JI. Eating disorder and socioeconomic class: anorexia nervosa and bulimia in nine communities. J Nerv Ment Dis 1987;175:620-3.
65. Hudson JI, Pope HG Jr, Jonas JM, Yurgelun-Todd D, Frankenburg FR. A controlled family history study of bulimia. Psychol Med 1987;l7:883-90.
66. Hudson JI, Pope HG Jr, Yurgelun-Todd D, Jonas JM, Frankenburg FR. A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry 1987;144:1283-7.
67. Keck PE Jr, Pope HG Jr, McElroy SL. Neuroleptic malignant syndrome: a prospective study. Am J Psychiatry 1987;144:1344-6.
68. Hudson JI, Hudson MS, Pope HG Jr, Griffing GT, Melby JC. Phenomenology and family history of affective disorder in Cushing’s disease. Am J Psychiatry 1987;144:951- 3.
69. Hudson JI, Pope HG Jr, Wurtman J, Yurgelun-Todd D, Mark S, Rosenthal NE. A controlled study of obese women with bulimia. J Nerv Ment Dis l988;l76:144-52.
70. Pope HG Jr, Hudson JI. Is bulimia a heterogeneous disorder? lessons from the history of medicine. Int J Eat Disord l988;7:155-66.
71. Keck PE Jr, Pope HG Jr, Hudson JI, McElroy SL, Kulick A. Lycanthropy: alive and well in the twentieth century. Psychological Med 1988;18:113-20.
72. Pope HG Jr, McElroy SL, Satlin A, Hudson JI, Keck PE Jr, Kalish R. Head injury, bipolar disorder, and response to sodium valproate. Compr Psychiatry l988;29:34-8.
73. Pope HG Jr, Jr, Katz DL. Affective and psychotic syndromes associated with use of anabolic steroids. Am J Psychiatry l988;145:487-90.
74. Hudson JI, Pope HG Jr, Yurgelun-Todd, D. Bulimia and major affective disorder: experience with 105 patients. Psychiatr Psychobiol l988; 3:37-47.
75. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI. Treatment of psychiatric disorders with sodium valproate: a series of 73 cases. Psychiatr Psychobiol 1988;3:8l-5.
76. Horne RL, Ferguson JM, Pope HG Jr, Hudson JI, Lineberry CG, Ascher J, Cato A. Treatment of bulimia with bupropion: a controlled multi-center trial. J Clin Psychiatry 1988;49:262-6.
77. Pope HG Jr, Cohen BM, Lipinski JF, Yurgelun-Todd D. DSM-III criteria for affective disorders and schizophrenia: a preliminary appraisal using family history findings. Psychiatr Psychobiol 1988;3:159-69.
78. McElroy SM, Pope HG Jr, Keck PE Jr, Hudson JI. Sodium valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol 1988;8:27579.
79. Pope HG Jr, McElroy SL, Nixon RA. Possible synergism between fluoxetine and lithium in refractory depression. Am J Psychiatry 1988;145:1292-4.
80. Pope HG Jr, Katz DL, Champoux R: Anabolic steroid use among 1010 college men. Physician Sportsmed 1988;16:75-81.
81. Pope HG Jr, Hudson JI, Yurgelun-Todd D. Depressive symptoms in bulimic, depressed, and non-psychiatric control subjects. J Affect Dis 1989;16:93-9.
82. Pope HG Jr, Hudson JI. Are the eating disorders associated with borderline personality disorder? A critical review. Int J Eat Disord 1989;8:1-9.
83. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI, Ferguson JM, Horne RL. Electrophysiologic abnormalities in bulimia and their implications for pharmacotherapy: a reassessment. Int J Eating Dis 1989;16:191-201.
84. Hudson JI, Pope HG Jr, Keck PE Jr, McElroy SL. Treatment of bulimia nervosa with trazodone: short-term response and long-term follow-up. Clin Neuropharmacol 1989;12(suppl 1):S38-S46.
85. Keck PE Jr, Pope HG Jr, Nierenberg AA. Autoinduction of hypertensive reactions by tranylcypromine? J Clin Psychopharmacol 1989;9:48-51.
86. Keck PE Jr, Vukovic A, Pope HG Jr, Nierenberg AA, Gribble GW, White K. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment. J Clin Psychopharmacol 1989;9:203-6.
87. Pope HG Jr, Keck PE Jr, McElroy SL, Hudson, JI. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 1989;9:254-9.
88. Keck PE Jr, Sebastianelli J, Pope HG Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a state psychiatric hospital. J Clin Psychiatry 1989;50:352-5.
89. Keck PE Jr, Pope HG Jr, Cohen BM, McElroy SL. Risk factors for neuroleptic malignant syndrome: a case-control study. Arch Gen Psychiatry 1989;46;914-8.
90. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Long-term pharmacotherapy of bulimia nervosa. J Clin Psychopharmacol 1989;9:385-6.
91. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Pharmacologic treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol 1989;9:358-60.
92. Pope HG Jr, Lichter SR. The reporting of AIDS. JAMA 1989;262:1949-50.
93. Hudson JI, Pope HG Jr. Fibromyalgia and psychopathology: is fibromyalgia a form of “affective spectrum disorder?” J Rheumatol 1989; 16(suppl 19):15-22.
94. Aranow RB, Hudson JI, Pope HG Jr, Grady TO, Laage TA, Bell IR, Cole JO. Elevated antidepressant plasma levels following addition of fluoxetine. Am J Psychiatry 1989;146:911-3.
95. Lipinski JR, Mallya G, Zimmerman P, Pope HG Jr. Fluoxetine-induced akathisia: clinical implications. J Clin Psychiatry 1989;50:339-42.
96. Gutierrez-Esteinou R, Pope HG Jr. Does fluoxetine lengthen electrically-induced seizures? Convul Therap 1989;5:344-8.
97. Kulick A, Pope HG Jr, Keck PE Jr. Lycanthropy and self-identification. J Nerv Ment Dis 1990;178:134-7.
98. Pope HG Jr, Yurgelun-Todd D. Schizophrenic individuals with bipolar first degree relatives. J Clin Psychiatry 1990;51:97-101.
99. Pope HG Jr, Katz DL. Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry 1990;51:28-31.
100. Hudson JI, Pope HG Jr. Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 1990;147:552-64.
101. Zanarini MC, Frankenburg FR, Pope HG Jr, Hudson JI,Yurgelun-Todd D, Cicchetti CJ. Axis II comorbidity of normal-weight bulimia. Compr Psychiatry 1990;30:20-4.
102. Pope HG Jr, Ionescu-Pioggia M, Aizley HG, Varma DK. Drug use and life-style among college undergraduates in 1989: a comparison with 1969 and 1978. Am J Psychiatry 1990;147:998-1001.
103. Woods BT, Yurgelun-Todd D, Benes FM, Frankenburg FR, Pope HG Jr, McSparren J. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry 1990;27:341-52.
104. Keck PE Jr, Seeler DC, Pope HG Jr, McElroy SL: Porcine stress syndrome: an animal model for neuroleptic malignant syndrome? Biol Psychiatry 1990;28:58-62.
105. Keck PE Jr, Pope HG Jr, Hudson JI, McElroy SL, Yurgelun-Todd D, Hundert EM. A controlled study of phenomenology and family history in outpatients with bulimia nervosa. Compr Psychiatry 1990;31:275-83.
106. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry 1991;48:62-8.
107. Hudson JI, Pope HG Jr, Goldenberg DL. Chronic fatigue syndrome. JAMA 1991;265:357.
108. Pope HG Jr, Aizley HG, Keck PE Jr, McElroy SL. Neuroleptic malignant syndrome: long-term follow-up of 20 cases. J Clin Psychiatry 1991;52:208-12.
109. McElroy SL, Hudson JI, Pope HG Jr, Keck PE Jr. Kleptomania: clinical characteristics and associated psychopathology. Psychol Med 1991;21:93-108.
110. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Morris D. Correlates of antimanic response to valproate. Psychopharmacol Bull 1991;27:127-33.
111. Pope HG Jr, Hudson JI. A supplemental interview for forms of “affective spectrum disorder.” Intl J Psychiatry in Medicine 1991;21:205-32.
112. McElroy SL, Pope HG Jr, Hudson JI, Keck PE Jr, White KL. Kleptomania: a report of 20 cases. Am J Psychiatry 1991;148:652-7.
113. Stoll AL, Pope HG Jr, McElroy SL. High dose fluoxetine: safety and efficacy in 27 cases. J Clin Psychopharmacol 1991;11:225-6.
114. Keck PE Jr, Pope HG Jr, McElroy SL. Declining frequency of the neuroleptic malignant syndrome. Am J Psychiatry 1991;148:880-2.
115. McElroy SL, Satlin A, Pope HG Jr, Keck PE Jr, Hudson JI. Treatment of compulsive shopping with antidepressants: A report of three cases. Ann Clin Psychiatry 1991;3:199- 204.
116. McElroy SL, Dessain E, Pope HG Jr, Cole JO, Keck PE Jr, Frankenburg F, Aizley HG, O’Brien S. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-4.
117. McElroy SL, Pope HG Jr, Woods BT, Hudson JI, Keck PE Jr, Aizley HG. Brain Electrical Activity Mapping (BEAM) in bulimia nervosa. Ann Clin Psychiatry 1991;3:281-6.
118. Hudson JI, Weiss RD, Pope HG Jr, McElroy SL, Mirin SM. Eating disorders among hospitalized substance abusers. Am J Drug Alcohol Abuse 1992;18:75-85.
119. Fluoxetine Bulimia Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992;49:139-147.
120. McElroy SL, Hudson JI, Pope HG Jr, Keck PE Jr, Aizley HG. The DSM-III-R impulse control disorders not elsewhere classified: Clinical characteristics and relationship to other psychiatric disorders. Am J Psychiatry 1992;149:318-27.
121. Pope HG Jr, Hudson JI. Is childhood sexual abuse a risk factor for bulimia nervosa? Am J Psychiatry 1992;149:455-63.
122. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Medicine 1992;92:363-7.
123. Williams JBW, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, Kane J, Pope HG Jr, Rounsaville B, Wittchen HU. The Structured Clinical Interview for DSM-III-R (SCID), II: Multi-site test-retest reliability. Arch Gen Psychiatry 1992;49:630-6.
124. Shedlack KJ, Pope HG, Jr. Anticonvulsant response in a case of anorexia nervosa and bipolar disorder associated with right-sided brain injury. Int J Eat Disord 1992;12:333-6.
125. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Faedda GL, Swann AC. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992;149:1633-44.
126. Hudson JI, Pope HG Jr, Keck PE Jr, Waternaux CM, Sullivan LE. Good sleep, bad sleep: a meta-analysis of polysomnographic measures in insomnia, depression, and narcolepsy. Biol Psychiatry 1992;32:958-75.
127. Phillips KA, McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry 1993;150:302-08.
128. Pope HG Jr, Yurgelun-Todd D. A family interview study of schizophrenia, schizoaffective disorder, and affective disorder: updated findings. European Psychiatry 1993;8:1-5.
129. Hudson JI, Pope HG Jr, Sullivan LE, Waternaux CM, Keck PE Jr, Broughton RJ. A meta-analysis of polysomnography in insomnia, depression, and narcolepsy. Sleep Res 1993;22:210.
130. Hudson JI, Pope HG Jr, Daniels SR, Horwitz RI. Insomnia, L-tryptophan, and EMS: nature of the association remains unclear. Sleep Res 1993;22:35.
131. Hudson JI, Lipinski JF, Keck PE Jr, Aizley HG, Vuckovic A, Zierk KC, Pope HG Jr. Sleep in schizophrenia. Sleep Res 1993;22:150.
132. Hudson JI, Pope HG Jr, Daniels SR, Horwitz RI. Eosinophilia-myalgia syndrome or fibromyalgia with eosinophilia? JAMA 1993;269:3108.
133. Hudson JI, Lipinski JF, Keck PE Jr., Aizley HG, Vuckovic A, Zierk KC, Pope HG Jr. Polysomnographic characteristics of schizophrenia in comparison with mania and depression. Biol Psychiatry 1993;34:191-3.
134. McElroy SL, Hudson JI, Phillips KA, Keck PE Jr, Pope HG Jr. Clinical and theoretical implications of a possible link between obsessive-compulsive disorder and impulse control disorders. Depression 1993;1:121-32.
135. McElroy SL, Phillips KA, Keck PE Jr, Hudson JI, Pope HG Jr. Body dysmorphic disorder: does it have a psychotic subtype? J Clin Psychiatry 1993;54:389-95.
136. Banov MD, Kulick AR, Oepen G, Pope HG Jr. A new identity for misidentification syndromes. Compr Psychiatry 1993;34:414-7.
137. Pope HG Jr, Katz DL, Hudson JI. Anorexia nervosa and “reverse anorexia” among 108 male bodybuilders. Compr Psychiatry 1993;34:406-9.
138. Hudson JI, Keck PE Jr, Lipinksi JF, Aizley HG, Pope HG Jr. Polysomnographic characteristics of bipolar depression. Depression 1993;1:227-30.
139. Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol 1993;13:397-408.
140. Tohen MT, Castillo J, Pope HG Jr, Herbstein J. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorder. J Clin Psychopharmacol 1994;14:67-70.
141. Gruber AJ Pope HG Jr. Cannabis psychotic disorder: does it exist? Am J Addictions 1994;3:72-83.
142. Pope HG Jr, Mangweth B, Negrao AB, Hudson JI, Cordas TA. Childhood sexual abuse and bulimia nervosa: a comparison of American, Austrian, and Brazilian women. Am J Psychiatry 1994;151:732-7.
143. Pope HG Jr, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroids: A controlled study of 160 athletes. Arch Gen Psychiatry 1994;51:375-82.
144. Ghaemi SN, Pope HG Jr. Lack of insight in psychotic and affective disorders: a review of empirical studies. Harvard Review of Psychiatry 1994;2:22-33.
145. Lipinski JF, Pope HG Jr. Do flashbacks represent obsessive-compulsive imagery? Compr Psychiatry 1994;35:245-7.
146. Choi PYL, Pope HG Jr. Violence towards women and illicit androgenic-anabolic steroid use. Ann Clin Psychiatry 1994;6:21-5.
147. McElroy SL, Keck PE Jr, Pope HG Jr, Smith J, Strakowski SM. Compulsive buying: A report of 20 cases. J Clin Psychiatry 1994;55:242-8.
148. Phillips KA, McElroy SL, Keck PE Jr, Hudson JI, Pope HG Jr. A comparison of delusional and non-delusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull 1994;30:179-86.
149. Hudson JI, Pope HG Jr. The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and pain. Balliere’s Clin Rheumatol 1994;8:839-56.
150. Mangweth B, Hudson JI, Pope HG Jr. Familenhintergrund bulimischer Frauen: ein crosskultureller Vergleich oesterreichischer und amerikanischer Studentinnen. Zeitschrift fur Klinische Psychologie, Psychopathologie und Psychotherapie 1995;43:57-74.
151. Pope HG Jr, Hudson JI. Can memories of childhood sexual abuse be repressed? Psychol Med 1995;25:121-6.
152. Hudson JI, Pope HG Jr. Does childhood sexual abuse cause fibromyalgia? Arthritis Rheum 1995;38:161-3.
153. Hudson JI, Pope HG, Daniels SR, Horwitz RI, Goldenberg DL. Fibromyalgia and eosinophilia-myalgia syndrome. J Musculoskeletal Pain 1995;3:63-75.
154. Mangweth B, Pope HG, Hudson JI. Bulimia nervosa in two cultures: a comparison of Austrian and American college students. Int J Eat Disord 1995;17:403-12.
155. Phillips KA, McElroy SL, Hudson JI, Pope HG Jr. Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry 1995; 56 (Suppl 4):41-51.
156. Pope HG Jr, Gruber AJ, Yurgelun-Todd D. The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend 1995;38:25-34.
157. Bond AJ, Choi PYL, Pope HG Jr. Assessment of attentional bias and mood in users and non-users of anabolic steroids. Drug Alcohol Depend 1995;37:241-5.
158. Olivardia R, Pope HG Jr, Mangweth B, Hudson JI. Eating disorders in college men. Am J Psychiatry 1995;152:1279-85.
159. Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH Jr.,The Fluoxetine Bulimia Nervosa Research Group. Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995;166: 660-6.
160. First MB, Spitzer RL, Gibbon M, Williams JBW, Davies M, Borus J, Howes MJ, Kane J, Pope HG Jr, Rounsaville B, Wittchen HU. The Structured Clinical Interview for DSM- III-R Personality Disorders (SCID-II) Part II: Multi-site test-retest reliability study. J Personality Disord 1995;9:92-104.
161. Ghaemi SN, Stoll AL, Pope HG Jr, Hebben N. Lack of insight in bipolar disorder: the acute manic episode. J Nerv Ment Dis 1995;183:464-7.
162. Kouri EM, Pope HG Jr, Katz DL, Oliva PS. Fat-free mass index in users and non-users of anabolic-androgenic steroids. Clin J Sport Med 1995;5:223-8.
163. Ram A, Cao Q, Keck PE Jr, Pope HG Jr, Otani K, Addonizio G, McElroy SL, Kaneko S, Redlichova M, Gershon ES, Gejman PV. Structural change in dopamine D2 receptor gene in a patient with neuroleptic malignant syndrome. Am J Med Genet 1995;60:228- 30.
164. Kouri E, Pope HG Jr, Yurgelun-Todd D, Gruber S. Attributes of heavy vs. occasional marijuana smokers in a college population. Biol Psychiatry 1995;38:475-81.
165. Kouri EM, Lukas SE, Pope HG Jr, Oliva PS. Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug Alcohol Depend 1995;40:73-9. Corrigendum to “Increased aggressive responding in male volunteers following the administation of gradually increasing doses of testosterone cypionate.” Drug Alcohol Depend 1998;50:255
166. Bodkin JA, Klitzman R, Pope HG Jr,. Treatment orientation and associated characteristics of North American academic psychiatrists. J Nerv Ment Dis 1995;183:729-35.
167. Pope HG Jr, Hudson JI. Does childhood sexual abuse cause adult psychiatric disorders? Essentials of methodology. J Psychiatry Law Fall 1995:363-81.
168. Pope HG Jr, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996;275:521-7.
169. Pope HG Jr, Hudson JI. “Recovered memory” therapy for eating disorders: implications of the Ramona verdict. Int J Eat Disord 1996;19:139-45.
170. Aguilera R, Becchi M, Casabianca H, Hatton CK, Catlin DH, Starcevic B, Pope HG Jr. Improved method of detection of testosterone abuse by gas chromatography/combustion/ isotope ratio mass spectrometry analysis of urinary steroids. J Mass Spectrometry 1996;31:169-76.
171. Hudson JI, Pope HG Jr. The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am 1996;22:285-303.
172. Gruber AJ, Hudson JI, Pope HG Jr. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine: fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am 1996;19:351-69.
173. Kouri EM, Pope HG Jr, Oliva PS. Changes in lipoprotein-lipid levels in normal men following administration of increasing doses of testosterone cypionate. Clin J Sport Med 1996;6:152-7.
174. McElroy SL, Pope HG Jr, Keck PE Jr, Hudson JI, Phillips KA, Strakowski SM. Are impulse control disorders related to bipolar disorder? Compr Psychiatry 1996;37:229-40.
175. Hudson JI, Carter WP, Pope HG Jr. Antidepressant treatment of binge-eating disorder: research findings and clinical guidelines. J Clin Psychiatry 1996;57[suppl 8]:73-9.
176. Mialet J-P, Pope HG Jr, Yurgelun-Todd D. Impaired attention in depressive states: a non-specific deficit. Psychol Med 1996;26:1009-20.
177. Pope HG Jr, Kouri EM, Powell KF, Campbell C, Katz DL. Anabolic-androgenic steroid use among 133 prisoners. Compr Psychiatry 1996;37:322-7.
178. Hudson JI, Pope HG Jr, Carter WP, Daniels SR. Fibromyalgia, psychiatric disorders, and assessment of the long-term outcome of eosinophilia-myalgia syndrome. J Rheumatol 1996;(suppl 46) 23:37-43.
179. Mangweth B, Pope HG Jr, Hudson JI, Biebl W. Bulimia nervosa in Austria and the United States: a controlled cross-cultural study. Int J Eat Disord 1996;20:263-70.
180. Mialet J-P, Bisserbe JC, Jacobs A, Pope HG Jr. Two-dimensional anxiety: a confirmation using computerized neuropsychological testing of attentional performance. Eur Psychiatry 1996;11:344-52.
181. Gruber AJ, Pope HG Jr, Brown ME. Do patients use marijuana as an antidepressant? Depression 1996;4:77-80.
182. Ghaemi SN, Hebben N, Stoll AL, Pope HG Jr. Neuropsychological aspects of lack of insight in bipolar disorder: a preliminary report. Psychiatry Res 1996;65:113-20.
183. Suppes T, Webb A, Carmody T, Gordon E, Gutierrez-Esteinou R, Hudson JI, Pope HG Jr. Is postictal electrical silence a predictor of response to electroconvulsive therapy? J Affective Disorders 1996;41:55-8.
184. Gruber AJ, Pope HG Jr, Oliva PS. Very long-term users of marijuana in the United States: a pilot study. Subst Use Misuse 1997;32:249-64.
185. Kouri EM, Pope HG Jr, Powell KF, Oliva PS, Campbell C. Drug use history and criminal behavior in 133 incarcerated men. Am J Drug Alcohol Abuse 1997;23:413-9.
186. Pope HG Jr, Jacobs A, Mialet J-P, Yurgelun-Todd D, Gruber S. Evidence for a sex- specific residual effect of cannabis on visuospatial memory. Psychother Psychosom. 1997;66:179-84.
187. Mangweth B, Pope HG Jr, Hudson JI, Olivardia R, Kinzl J, Biebl W. Eating disorders in Austrian men: an intra-cultural and cross-cultural comparison study. Psychother Psychosom 1997;66:214-21.
188. Pope HG Jr, Gruber AJ, Choi PY, Olivardia R, Phillips KA. Muscle dysmorphia: an underrecognized form of body dysmorphic disorder. Psychosomatics 1997;38:548-57.
189. Anfang MK, Pope HG Jr. Treatment of neuroleptic-induced akathisia with nicotine patches. Psychopharmacology 1997;134:153-6.
190. Mangweth B, Pope HG Jr, Ionescu-Pioggia M, Kinzl J, Biebl W. Drug use and lifestyle among college students in Austria and the United States. Subst Use Misuse 1997;32:461- 73.
191. Hudson JI, Chase EA, Pope HG Jr. Eye movement desensitization and reprocessing in eating disorders: caution against premature acceptance. Int J Eat Disord 1998;23: 1-5.
192. Pope HG Jr, Hudson JI, Bodkin JA, Oliva P. Questionable validity of ‘dissociative amnesia’ in trauma victims. Evidence from prospective studies. Br J Psychiatry 1998;172:210-5.
193. Klitzman R, Bodkin JA., Pope, HG Jr. Sexual orientation and associated characteristics among North American academic psychiatrists. J Sex Res 1998;35:282-7.
194. Gruber AJ, Pope HG Jr. Ephedrine abuse among 36 female weightlifters. Am J Addictions 1998;7:256-61.
195. Hudson, JI, McElroy SL, Raymond NC, Crow S, Keck PE Jr, Carter WP, Mitchell JE, Strakowski SM, Pope HG Jr, Coleman B, Jonas JM. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled double-blind trial. Am J Psychiatry 1998;155:1756-62.
196. Halpern JH, Pope HG Jr. Do hallucinogens cause residual neuropsychological toxicity? Drug Alcohol Depend 1999;53:247-56.
197. Pope HG Jr, Oliva PS, Hudson JI, Bodkin JA, Gruber AJ. Attitudes towards DSM-IV dissociative disorders diagnoses among board-certified American psychiatrists. Am J Psychiatry 1999;156:321-3.
198. Kouri EM, Pope HG Jr, Lukas SE. Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology 1999;143:302-8
199. Pope HG Jr, Olivardia R, Gruber A, Borowiecki J. Evolving ideals of male body image as seen through action toys. Int J Eat Disord 1999;26:65-72.
200. Wines JD Jr, Gruber AJ, Pope HG Jr, Lukas SE. Nalbuphine hydrochloride dependence in anabolic steroid users. Am J Addictions 1999;8:161-4.
201. Gruber AJ, Pope HG Jr. Compulsive weightlifting and anabolic drug abuse among women rape victims. Compr Psychiatry 1999;40:23-7.
202. Mangweth B, Hudson JI, Pope HG Jr, Oberleit S, DeCol C, Kinzl J, Biebl W. Knowledge of calories and its effect on eating behavior in overweight, normal weight, and underweight individuals. Eating Weight Disord 1999; 4:165-8.
203. Aguilera R, Catlin DH, Becchi M, Phillips A, Wang C, Swerdloff RS, Pope HG, Hatton CK. Screening urine for exogenous testosterone by isotope ratio mass spectrometric analysis of one pregnanediol and two androstanediols. J Chromatography B 1999;727:95-105.
204. Gruber AJ, Pope HG Jr. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom 2000;69:19-26.
205. Pope HG Jr., Kouri EM, Hudson JI. The effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry 2000;57:133-40.
206. Klitzman RL, Pope HG Jr, Hudson JI. MDMA (”ecstasy”) abuse and high-risk sexual behaviors among 169 gay men and bisexual men. Am J Psychiatry 2000;157:1162-4.
207. Olivardia R, Pope HG Jr, Hudson JI. ‘Muscle dysmorphia’ in male weightlifters: a case-control study. Am J Psychiatry 2000;157:1291-6.
208. Pope HG Jr, Gruber AJ, Mangweth B, Bureau B, deCol C, Jouvent R, Hudson JI. Body image perception among men in three countries. Am J Psychiatry 2000;157:1297-301.
209. Gruber AJ, Pope HG, Borowiecki JJ, Cohane G. The development of the somatomorphic matrix: a bi-axial instrument for measuring body image in men and women. In K. Norton, T. Olds and J. Dollman (Eds.). Kinanthropometry VI. Adelaide: International Society for the Advancement of Kinanthropometry, pp. 217-231, 2000.
210. Kouri EM, Pope HG Jr. Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharm. 2000;8:483-492.
211. Bowden CL, Calabrese JR, McElroy SL, Hirschfeld RMA, Petty F, Gyulai L, Pope HG Jr, Chou JC, Keck PE Jr, Rhodes LJ, Swann AC, Wozniak PJ. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000;57:481-489.
212. Piper A Jr, Pope HG Jr, Borowiecki JJ. Custer’s last stand: Brown, Scheflin, and Whitfield’s latest attempt to salvage “dissociative amnesia.” J Psychiatry Law 2000;28 Summer:149-213.
213. Leit RA, Pope HG Jr, Gray JJ. Cultural expectations of muscularity in men: the evolution of Playgirl centerfolds. Int J Eating Disord 2001;29:90-3.
214. Mangweth B, Pope HG Jr, Kemmler G, Ebenbichler C, Hausmann A, DeCol C, Kinzl J, Biebl W. Body image and psychopathology in male bodybuilders. Psychother Psychosom 2001;70:38-43.
215. Hudson JI, Laird NM, Betensky RA, Keck PE Jr, Pope HG Jr. Multivariate logistic regression for familial aggregation of two disorders: II. Analysis of studies of eating and mood disorders. Am J Epidemiology 2001;153:506-14.
216. Halpern JH, Pope HG Jr. Hallucinogens on the internet: a vast new source of “underground”drug information. Am J Psychiatry 2001;158:481-3.
217. Cohane GH, Pope HG Jr. Body image in boys: a review of the literature. Int J Eating Disord. 2001;29:373-9.
218. Kanayama G, Gruber AJ, Pope HG Jr, Borowiecki JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom 2001;70:137-40.
219. Lalonde JK, Hudson JI, Gigante RA, Pope HG Jr. Canadian and American Psychiatrists’ attitudes toward dissociative disorders diagnoses. Can J Psychiatry 2001;46:407-12.
220. Pope HG, Jr., Olivardia R, Borowiecki JJ, Cohane GH. The growing commercial value of the male body: a longitudinal survey of advertising in women’s magazines. Psychother Psychosom 2001;70:189-92.
221. Cannell J, Hudson JI, Pope HG Jr. Standards for informed consent in recovered memory therapy. J Am Acad Psychiatry Law 2001;29:138-47.